Early PSA decrease is an independent predictive factor of clinical failure specific survival in patients with localized prostate cancer treated with radiotherapy combined or not with androgen deprivation therapy
Date
2010
Authors
Heyns C.F.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
antiandrogen, prostate specific antigen, androgen deprivation therapy, antigen detection, brachytherapy, cancer mortality, cancer survival, drug response, external beam radiotherapy, high risk population, human, letter, priority journal, prognosis, prostate cancer, prostatectomy, radiation dose, treatment failure, tumor cell destruction, Adenocarcinoma, Androgen Antagonists, Antineoplastic Agents, Hormonal, Combined Modality Therapy, Down-Regulation, Early Diagnosis, Humans, Male, Prognosis, Prostate-Specific Antigen, Prostatic Neoplasms, Radiotherapy Dosage, Survival Analysis, Time Factors, Treatment Failure
Citation
Annals of Oncology
21
4
21
4